About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5428767
Allelic
Composition
Gt(ROSA)26Sortm1.1(Maml1/EGFP)Hri/?
Foxa2tm3.1(icre)Heli/Foxa2+
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Foxa2tm3.1(icre)Heli mutation (0 available); any Foxa2 mutation (26 available)
Gt(ROSA)26Sortm1.1(Maml1/EGFP)Hri mutation (0 available); any Gt(ROSA)26Sor mutation (944 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
endocrine/exocrine glands
• embryos show an increase in Neurog3+ve cells at E9.5; by E10.5, an increase in glucagon+ve cells is seen
• at E15.5, the insulin +ve area of the pancreatic tissue is reduced by 65% compared to control embryos
• proximal-distal patterning is altered in the embryonic pancreas; at E15.5, Nkx6-1+ve, Ptf1a-ve cells are reduced in the proximal domain by 75% while Hnf1b and DBA+ve cells are reduced in number
• at E12.5, Nkx6-1+ve Ptf1a-ve are present, but reduced in numbers by 50% compared to controls along with a corresponding increase in Nkx6-1-ve Ptf1a+ve cells
• at E15.5, the insulin +ve area of the pancreatic tissue is reduced by 65% compared to control embryos

cellular
• at E15.5, the insulin +ve area of the pancreatic tissue is reduced by 65% compared to control embryos


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory